Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Neurotrope, Inc.
  6. Summary
    NTRP   US64129T2078

NEUROTROPE, INC.

(NTRP)
 SummaryChartsNewsCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq
03/25/2020 03/26/2020 03/27/2020 03/30/2020 03/31/2020 Date
0.8386 0.89 0.86 0.92 0.82 Last
197281 110185 77537 231915 105449 Volume
-6.82% +6.13% -3.37% +6.98% -10.87% Change
All news about NEUROTROPE, INC.
2020NEUROTROPE, INC.  : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
2020NEUROTROPE, INC.  : Other Events (form 8-K)
AQ
2020NEUROTROPE, INC.  : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020NEUROTROPE  : Management's Discussion and Analysis of Financial Condition and Re..
AQ
2020NEUROTROPE, INC.  : Other Events (form 8-K)
AQ
2020NEUROTROPE, INC.  : Entry into a Material Definitive Agreement, Financial Statem..
AQ
2020NEUROTROPE  : Management's Discussion and Analysis of Financial Condition and Re..
AQ
2020NEUROTROPE, INC.  : Entry into a Material Definitive Agreement, Financial Statem..
AQ
2020NEUROTROPE, INC.  : Other Events (form 8-K)
AQ
2020NEUROTROPE, INC.  : Entry into a Material Definitive Agreement, Financial Statem..
AQ
2020NEUROTROPE  : Announces Strategic Partnership with BryoLogyx for Supply of Synth..
AQ
2020NEUROTROPE  : Management's Discussion and Analysis of Financial Condition and Re..
AQ
2020NEUROTROPE, INC.  : Regulation FD Disclosure, Other Events (form 8-K)
AQ
2020NEUROTROPE  : Launches New Long-Term Clinical Trial of Bryostatin with the Natio..
PU
2020NEUROTROPE, INC.  : Entry into a Material Definitive Agreement, Other Events, Fi..
AQ
More news
News in other languages on NEUROTROPE, INC.

- No features available -

More news
Chart NEUROTROPE, INC.
Duration : Period :
Neurotrope, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
NameTitle
Daniel L. Alkon President & Chief Scientific Officer
Robert Weinstein CFO, Secretary, Treasurer & Executive VP
Joshua Nathaniel Silverman Chairman
Alan J. Tuchman Chief Medical Officer
William S. Singer Vice Chairman